Cargando…
Zinc-α2-glycoprotein as an inhibitor of amine oxidase copper-containing 3
Zinc-α2-glycoprotein (ZAG) is a major plasma protein whose levels increase in chronic energy-demanding diseases and thus serves as an important clinical biomarker in the diagnosis and prognosis of the development of cachexia. Current knowledge suggests that ZAG mediates progressive weight loss throu...
Autor principal: | Romauch, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685929/ https://www.ncbi.nlm.nih.gov/pubmed/32315567 http://dx.doi.org/10.1098/rsob.190035 |
Ejemplares similares
-
Human Copper-Containing Amine Oxidases in Drug Design and Development
por: Vakal, Serhii, et al.
Publicado: (2020) -
Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors
por: Carpéné, Christian, et al.
Publicado: (2019) -
Amine Oxidase Inhibitors
por: Giarman, Nicholas J.
Publicado: (1960) -
Copper-containing amine oxidases contribute to terminal polyamine oxidation in peroxisomes and apoplast of Arabidopsis thaliana
por: Planas-Portell, Joan, et al.
Publicado: (2013) -
Copper-Containing Amine Oxidases and FAD-Dependent Polyamine Oxidases Are Key Players in Plant Tissue Differentiation and Organ Development
por: Tavladoraki, Paraskevi, et al.
Publicado: (2016)